Skip to content

Medicated Nasal Drops and Head massage in Nidranash

“A comparative clinical study to check the efficacy of Tungdrumadi Taila Pratimarsh Nasya and Shiroabhyanga in the management of Nidranash ?

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047392
Enrollment
30
Registered
2022-11-17
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F419- Anxiety disorder, unspecified

Interventions

None listed

Sponsors

National institute of ayurveda jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a)Patients between 18-60 years of age. b)Patients with clinical signs and symptoms of Nidranash. c)Patients of Insomnia with mild hypertension, mild diabetic will be included for the present study. d)Patients of either sex irrespective of their occupation, religion and socio-economic status. e)Patients willing and able to participate in trial.

Exclusion criteria

Exclusion criteria: a)Patient below 18 and above 60 years of age. b)Patients with severe systemic disorders as Uncontrolled Hypertension, Cardiac Problem, Uncontrolled Diabetes Mellitus, Tuberculosis, Leprosy, Paralysis, Malignant disease etc. c)Pregnant and Lactating Mothers. d)Patient under any psychic mental condition. e)Patient taking any Narcotics Medication. f)Patients diagnosed with any congenital or hereditary mental disorder.

Design outcomes

Secondary

MeasureTime frame
Subjective parameters : Jrimbha (Yawning) Tandra (Drowsiness) Angamarda (Malaise) Arati and klama (Fatigue and Inertness) Shirahshoola (Headache) Jadya(Heaviness in the body) Aapakti(Indigestion) Timepoint: Baseline of the day 0th- after completion of the trial 31th day - 45th of the day - 60th of the day

Primary

MeasureTime frame
PSQI Scale (Pittsburg sleep quality index) •Component 1: Subjective sleep quality •Component 2: Sleep latency •Component 3: Sleep duration •Component 4: Sleep efficiency •Component 5: Sleep disturbance •Component 6: Use of sleep medication •Component 7: Daytime dysfunction Timepoint: Baseline of the day 0th- after completion of the trial 31th day - 45th of the day - 60th of the day

Countries

India

Contacts

Public ContactDr Pooja Rani

National institute of ayurveda jaipur

drsurendravedpathak50@gmail.com9422711158

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026